Companies
Abraxis / SDIX
Microcystins/Nodularins Determination Kit — ELISA-based lab toxin-concentration confirmation testing.
- Country
- United States
US
Coverage
| CN | EU | US | |
|---|---|---|---|
| sensors | ✓ | ✓ | ✓ |
Regulatorsepa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | The company has never raised funding. | prospeo.io |
| Revenue | $10M - $25M annually | prospeo.io |
| Headcount | 21-50 employees | prospeo.io |
| Headquarters | Horsham, Pennsylvania, United States | prospeo.io |
| Production site | 124 Railroad Drive, Warminster, Pennsylvania, United States | govconinabox.com · goldstandarddiagnostics.com |
| Regulatory approval | EPA Method 546 compliant (e.g., Microcystins-ADDA ELISA) | pmc.ncbi.nlm.nih.gov · epa.gov |
| Certification | EPA ETV verified (Environmental Technology Verification) medium confidence | goldstandarddiagnostics.us |
Independent sources: epa.gov · goldstandarddiagnostics.com · goldstandarddiagnostics.us · govconinabox.com · pmc.ncbi.nlm.nih.gov · prospeo.io
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Real-time bio-toxin monitoring in water | sensors | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.